Posted in Markets

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

on
Admin




Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.



Source link

You May Also Like

More From Author

Links 6/17/2025 | naked capitalism

Why You Can’t Appreciate One Without the Other

Leave a Reply

Your email address will not be published. Required fields are marked *